B. Caughey

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Bennett Caughey, B. Caughey, Bennett Adam Caughey, Bennett A. Caughey, Bennett A Caughey
Publication record
21 papers · 2,686 citations · H-index 9

PAPERS

Overcoming barriers to adoption of precision medicine in community oncology centers in the rural southeastern United States using novel informatics tools and academic collaborations.
20230 citationsauthor #1
Chemotherapeutic sensitivity in colorectal cancer expressing low RNA of wild type homologous recombination genes.
20231 citationsauthor #7
Identification of an optimal circulating tumor DNA (ctDNA) shedding threshold to detect actionable driver mutations in colorectal and pancreatic adenocarcinoma.
20220 citationsauthor #1
PB2159: FREQUENCY OF PRACTICE-CHANGING FINDINGS IDENTIFIED BY COMPREHENSIVE GENOMIC PROFILING IN NON-MYELOID HEMATOLOGIC MALIGNANCIES
20220 citationsauthor #4
Abstract 2466: Designing an intuitive visualization of BRCAness scores for clinicians
20190 citationsauthor #3
DNA methylation markers for diagnosis and prognosis of common cancers
2017399 citationsauthor #14
Circulating tumour DNAmethylation markers for diagnosis andprognosis of hepatocellular carcinoma
20175 citationsauthor #13
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.
2017724 citationsauthor #13
MicroRNA Expression Profile on Solid Subtype of Invasive Lung Adenocarcinoma Reveals a Panel of Four miRNAs to Be Associated with Poor Prognosis in Chinese Patients
201614 citationsauthor #6
Tools to study splicing factor mutations in MDS: Human HSC isolation and CRISPR/Cas9 genome editing
20160 citationsauthor #1
Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA
2015123 citationsauthor #4
Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-Infected Patients Treated with Highly Active Antiretroviral Therapy (HAART)
201510 citationsauthor #7
Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.
2014380 citationsauthor #3
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients.
2014548 citationsauthor #8
O-024 Next-generation sequencing of 213 MDS patient samples identifies mutation profiles associated with response to hypomethylating agents and overall survival
20135 citationsauthor #6
Functional Defects In Neutrophils Derived From Ezh2 Null Mice
20133 citationsauthor #1
Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.
2012455 citationsauthor #3
Detection of Recurrent Mutations by Pooled Targeted Next-Generation Sequencing in MDS Patients Prior to Treatment with Hypomethylating Agents or Stem Cell Transplantation
20128 citationsauthor #6
Validation of a Prognostic Model and the Impact of SF3B1, DNMT3A, and Other Mutations in 289 Genetically Characterized Lower Risk MDS Patient Samples
201110 citationsauthor #3
Streaks in Baseball: A Matter of Chance?
20020 citationsauthor #1
CALIFORNIA STATE SCIENCE FAIR 2002 PROJECT SUMMARY
20020 citationsauthor #1

TIMELINE

2002 0 citations

2011 10 citations

2012 463 citations

2013 8 citations

2014 928 citations

2015 133 citations

2016 14 citations

2017 1,128 citations

2019 0 citations

2022 0 citations

2023 1 citations

B. Caughey

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT